Molecules · 2023 · 12 citations · 26 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryNeuropharmacologyOrganic ChemistryDopaminergic PharmacologyEnzyme InhibitionMonoamine NeurochemistrySerotonergic PharmacologyStructure-activity Relationship AnalysisHalf-maximal Inhibitory ConcentrationIndole DerivativesMedicinal Chemistry ApplicationsMonoamine Oxidase InhibitionMonoamine Oxidase InhibitorsMonoamine OxidasesParkinson's Disease PharmacotherapyParkinson’s Disease Pharmacotherapy
Monoamine oxidase (MAO, EC 1.4.3.4) is responsible for the oxidative breakdown of both endogenous and exogenous amines and exists in MAO-A and MAO-B isomers. Eighteen indole-based phenylallylidene derivatives were synthesized via nucleophilic addition reactions comprising three sub-series, IHC, IHMC, and IHNC, and were developed and examined for their ability to inhibit MAO. Among them, compound IHC3 showed a strong MAO-B inhibitory effect with an IC50 (half-maximal inhibitory concentration) value of 1.672 μM, followed by IHC2 (IC50 = 16.934 μM). Additionally, IHC3 showed the highest selectivity index (SI) value of >23.92. The effectiveness of IHC3 was lower than the reference pargyline (0.14 μM); however, the SI value was higher than pargyline (17.16). Structurally, the IHC (-H in the B-ring) sub-series exhibited relatively stronger MAO-B inhibition than the others. In the IHC series, IHC3 (-F in the A-ring) exhibited stronger MAO-B suppression than the other substituted derivatives in the order -F > -Br > -Cl > -OCH3, -CH3, and -H at the 2-position in the A-ring. In the reversibility and enzyme kinetics experiments, IHC3 was a reversible inhibitor with a Ki value of 0.51 ± 0.15 μM for MAO-B. Further, it was observed that IHC3 greatly decreased the cell death caused by rotenone in SH-SY5Y neuroblastoma cells. A molecular docking study of the lead molecule was also performed to determine hypothetical interactions in the enzyme-binding cavity. These findings suggest that IHC3 is a strong, specific, and reversible MAO-B inhibitor that can be used to treat neurological diseases.
26
Biological activities of isatin and its derivatives.
Surendra N. Pandeya, Sivakumar Smitha, Mayank Jyoti et al. · PubMed · 2005 · 345 citations · Full text
MAO-inhibitors in Parkinson's Disease
Peter Riederer, Gerd Laux · Experimental Neurobiology · 2011 · 213 citations · Full text